Regulation of cytotoxic T-cell differentiation and exhaustion by mTOR signaling

Researchers describe molecular signalling regulated by mTOR among memory and exhausted cytotoxic CD8+ T lymphocytes.

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s disease – Pharmaceutical Technology

Kisunla is an amyloid-targeting therapy intended to treat patients with early symptomatic Alzheimer’s disease. Credits: rafapress/Shutterstock.com Eisai and Biogen must now brace for competition as

July 4, 2024

Argonne receives $21.7 million to advance cancer and vaccine discoveries

The U.S. Department of Energy’s (DOE) Argonne National Laboratory will use its world-leading capabilities in artificial intelligence (AI) and high performance computing to research novel

November 15, 2024

Dental care is in crisis. But it’s also a moment of opportunity

While staffing crises at hospitals continue to make headlines, dental care — too often overlooked and treated as separate from medical — is also experiencing

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.